stemsavelogo

Select Country

877-783-6728 (877-StemSave)

StemSave Blog

Cartilage Repair with Stem Cells Receives FDA Approval

Posted by davids@stemsave.com on Sep 11, 2018 2:46:00 PM

A stem cell graft to treat cartilage injuries has been approved by the FDA. Created by the biotechnology company Vericel, the procedure is called Matrix Associated Chondrocyte Implantation (MACI), and involves obtaining stem cells from the patient and culturing them in a lab. The cultured cells are then placed into a matrix to create layers of 3D tissue, which is then implanted back into the knee to repair the injured cartilage. This treatment is specifically targeted to younger patients [recall - younger stem cells are more plentiful and more active] who have experienced what is called a focal chondral defect, which is a lesion or hole in the cartilage due to an injury. This treatment is significant because these cartilage lesions often develop into osteoarthritis, with serious implications for the patient’s future quality of life. Hence, utilization of this FDA approved autologous stem cell treatment would not only address the physical distress of the condition but would also effectively mitigate the concerns and stress patients experience regarding future complications.

Read More

Topics: cartilage regeneration, focal chondral defects, stem cell grown cartilage, osteoarthritis, stem cell graft

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

    Recent Posts

    Posts by Topic

    see all